000 | 01505 a2200421 4500 | ||
---|---|---|---|
005 | 20250517043317.0 | ||
264 | 0 | _c20160919 | |
008 | 201609s 0 0 eng d | ||
022 | _a2567-689X | ||
024 | 7 |
_a10.1160/TH15-02-0128 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avan den Besselaar, A M H P | |
245 | 0 | 0 |
_aPoint-of-care testing and INR within-subject variation in patients receiving a constant dose of vitamin K antagonist. _h[electronic resource] |
260 |
_bThrombosis and haemostasis _cNov 2015 |
||
300 |
_a1260-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcenocoumarol _xadministration & dosage |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
650 | 0 | 4 | _aData Accuracy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInternational Normalized Ratio _xinstrumentation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPoint-of-Care Testing |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aSelf Care |
650 | 0 | 4 |
_aVitamin K _xantagonists & inhibitors |
650 | 0 | 4 |
_aWarfarin _xadministration & dosage |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aBiedermann, Joseph S | |
700 | 1 | _aKruip, Marieke J H A | |
773 | 0 |
_tThrombosis and haemostasis _gvol. 114 _gno. 6 _gp. 1260-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1160/TH15-02-0128 _zAvailable from publisher's website |
999 |
_c25101227 _d25101227 |